10x Genomics Inc. (TXG)
10x Genomics Statistics
Share Statistics
10x Genomics has 124.85M shares outstanding. The number of shares has increased by 2.17% in one year.
| 124.85M |
| 2.17% |
| 1.03% |
| 87.07% |
| 116.19M |
| 340 |
| 0.01% |
Short Selling Information
The latest short interest is 16.02M, so 13.01% of the outstanding shares have been sold short.
| 16.02M |
| 13.01% |
| 21.57% |
| 5.32 |
Valuation Ratios
The PE ratio is -9.47 and the forward PE ratio is -11.49. 10x Genomics's PEG ratio is 0.31.
| -9.47 |
| -11.49 |
| 2.83 |
| 1.8 |
| 2.44 |
| -301.92 |
| 0.31 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 10x Genomics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.12.
| 4.97 |
| 4.26 |
| 0.12 |
| -0.62 |
| -14.42 |
| -48639.75 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $467,676.11 |
| $-139,836.91 |
| 1,306 |
| 0.66 |
| 2.36 |
Taxes
| 4.93M |
| -2.77% |
Stock Price Statistics
The stock price has increased by -45.67% in the last 52 weeks. The beta is 1.98, so 10x Genomics's price volatility has been higher than the market average.
| 1.98 |
| -45.67% |
| 9.02 |
| 13.49 |
| 62.03 |
| 3,783,846 |
Income Statement
In the last 12 months, 10x Genomics had revenue of 610.78M and earned -182.63M in profits. Earnings per share was -1.52.
| 610.78M |
| 414.48M |
| -194.56M |
| -182.63M |
| -133.99M |
| -177.7M |
| -1.52 |
Balance Sheet
The company has 344.07M in cash and 82.61M in debt, giving a net cash position of 261.45M.
| 344.07M |
| 82.61M |
| 261.45M |
| -1.47B |
| 903.39M |
| 471.83M |
Cash Flow
In the last 12 months, operating cash flow was 6.66M and capital expenditures -12.39M, giving a free cash flow of -5.73M.
| 6.66M |
| -12.39M |
| -5.73M |
| -0.05 |
Margins
Gross margin is 67.86%, with operating and profit margins of -31.85% and -29.9%.
| 67.86% |
| -31.85% |
| -29.09% |
| -29.9% |
| -21.94% |
| -31.85% |
| -0.94% |
Dividends & Yields
TXG does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for TXG is $15, which is 38.9% higher than the current price. The consensus rating is "Hold".
| $15 |
| 38.9% |
| Hold |
| 15 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jul 17, 2006. It was a backward split with a ratio of 1:2.
| Jul 17, 2006 |
| backward |
| 1:2 |
Scores
| 1.58 |
| 5 |